As a SNARE binding protein, tomosyn has been reported to negatively regulate synaptic exocytosis via arresting syntaxin-1 and SNAP-25 into a nonfusogenic product that precludes synaptobrevin-2 entry, raising the question how the assembly of the SNARE complex is achieved. Here, we have investigated new functions of tomosyn in SNARE complex formation and SNAREmediated vesicle fusion. Assisted by NSF/a-SNAP, syntaxin-1 escapes tomosyn arrest and assembles into the Munc18-1/syntaxin-1 complex. Munc13-1 then catalyzes the transit of syntaxin-1 from the Munc18-1/syntaxin-1 complex to the SNARE complex in a manner specific to synaptobrevin-2 but resistant to tomosyn. Our data suggest that tomosyn ensures SNARE assembly in a way amenable to tight regulation by Munc18-1 and Munc13-1.
Neurotransmitter release by synaptic exocytosis requires fast fusion of synaptic vesicles (SV) with the presynaptic membrane in response to Ca 2+ [1] [2] [3] . Soluble NSFattachment protein receptors (SNAREs) play a central function in this process [4] . Neuronal SNAREs are composed of two Q-SNAREs, syntaxin-1 (Q a ) and SNAP-25 (Q b and Q c ) in the plasma membrane, and one R-SNARE, synaptobrevin-2/VAMP2 in the vesicle membrane [5] . The three SNAREs form a highly stable four-helical bundle called the SNARE complex that is believed to bridge the two membranes and drive membrane fusion [6] [7] [8] . In neurons, SNARE-mediated membrane fusion is spatially and temporally regulated by a number of accessory proteins for the exquisite regulation of neurotransmitter release [9] . The critical proteins include (a) the SM (Sec1/Munc18-like) protein Munc18-1 and the complexes associated with tethering containing helical rods (CATCHR) related protein Munc13, which highly regulate SNARE complex formation; (b) the neuronal specific proteins complexin and synaptotagmin-1, which confer the Ca 2+ sensitivity to the SNARE complex, enabling fusion to occur in submillisecond timescale; and (c) NSF and a-SNAP, which disassemble the SNARE complex to recycle the SNAREs for another round of fusion. Despite that the regulatory functions of these proteins in SNAREAbbreviations BDPY, BODIPY FL N-(2-aminoethyl)-maleimide; CATCHR, complexes associated with tethering containing helical rods; FRET, fluorescence resonance energy transfer; SNAREs, soluble NSF-attachment protein receptors; SV, synaptic vesicle; TMR, tetramethylrhodamine-5-maleimide; VLD, VAMP-like domain. mediated membrane fusion have been extensively studied both in vivo and in vitro, the sequence of the regulatory events that leads to SNARE complex formation still remains enigmatic.
Munc18-1 binds tightly with syntaxin-1 to form a 'closed' heterodimeric complex, chaperoning proper localization of syntaxin-1 to the plasma membrane and inhibiting entry of syntaxin-1 into the SNARE complex [10, 11] . It was demonstrated that Munc13-1 catalyzes the transition of the Munc18-1/syntaxin-1 complex to the SNARE complex in the presence of SNAP-25 and synaptobrevin-2 [12, 13] . Supporting such a scenario, increasing evidence revealed that Munc18-1 and Munc13-1 cooperate to ensure proper SNARE complex assembly [14] , and stabilize primed synaptic vesicles (SV) in a manner resistant to NSF/a-SNAP [15, 16] . These results illustrate a Munc18-Munc13 route to SNARE complex formation and suggest that the Munc18-1/syntaxin-1 complex may constitute a welldefined starting point amenable to exquisite regulation of exocytosis. On the other hand, the syntaxin-1/SNAP-25 complex may serve as another possible starting point for exocytosis, because this complex is steadily reactive for synaptobrevin-2 binding and lipid mixing between liposomes [7] . In line with this, there are indications that Munc18-1 acts with the syntaxin-1/SNAP-25 complex to facilitate membrane fusion without the need for Munc13 [17, 18] , despite the essential nature of Munc13 for release in vivo [19, 20] . In addition, recent in vitro studies have identified a syntaxin-1/SNAP-25/Munc18-1 tripartite complex that exhibits high reactivity for SNARE complex formation [21] , implying another binding mode of Munc18-1 that is different from the Munc18-1/syntaxin-1 complex. In this scenario, Munc18-1 is proposed to stabilize a 1 : 1 syntaxin-1/ SNAP-25 complex, similar to the role of the C-terminal fragment of synaptobrevin-2 (residues 49-96) [21] [22] [23] .
In addition to Munc18-1 and Munc13-1, tomosyn has been identified as one of the regulatory protein for SNARE complex formation [24] . Tomosyn has long been thought to sequester syntaxin-1 and SNAP-25 on the plasma membrane through its C-terminal VAMPlike domain (VLD) [25] . It has been suggested that tomosyn negatively regulates SNARE-mediated exocytosis [26] [27] [28] [29] . Indeed, the structural study revealed that the tomosyn-VLD, syntaxin-1 and SNAP-25 could form a tight four-helical bundle (referred to as the tomosyn-SNARE complex hereafter) [25] , similar to that of the SNARE complex containing synaptobrevin-2. These data support a notion that the tomosyn-SNARE complex likely acts as a nonfusogenic complex (as it lacks a transmembrane domain) to inhibit exocytosis.
Despite these advances, how the actions of Munc18-1 and tomosyn fit into the overall pathway of SNARE complex formation in synaptic exocytosis remains incompletely understood. In this study, we systematically investigated the regulatory function of the tomosyn-VLD in SNARE complex formation and membrane fusion. Our data provide a coherent picture where the tomosyn-VLD coordinates with Munc18-1 and Munc13-1 to confer precise regulation on SNARE-mediated exocytosis.
Material and methods

Plasmids and protein purification
The VLD of human tomosyn (also known as syntaxin binding protein 5, isoform b, uniprot entry Q5T5C0-2) used in this study comprises residues 1031-1115, which was cloned into pGEX-6p-1 vector (GE Healthcare, Chicago, IL, USA). The cytoplasmic domain of rat syntaxin-1a (residues 2-253), full-length rat synaptobrevin-2 and its cytoplasmic domain (residues 29-93), rat Munc13-1 MUN domain (also known as MUN 933 , residues 933-1407, EF, 1453-1531), full-length rat Munc18, full-length Cricetulus griseus NSF and fulllength Bos taurus a-SNAP were all cloned into pGEX-KG vector. Full-length rat syntaxin-1a, full-length rat synaptotagmin-1, full-length human SNAP-25a (with its four cysteines mutated to serines) and its C-terminal 9-residue truncation (known as SNAP-25 D9) were constructed into pET28a vector (Novagen, Darmstadt, Germany). Coexpressed rat Munc18-1 and rat syntaxin-1a cytoplasmic domain (residues 1-261) were cloned to pETDuet-1 vector (Novagen). Rat Munc13-1 C 1 -C 2 B-MUN fragment (residues 529-1407, EF, 1453-1531) was cloned into pFastBac TM HtB vector (Invitrogen, Carlsbad, CA, USA). Cysteine point mutations for fluorescent labeling (Synaptobrevin-2 S61C and N29C, SNAP-25a S187C, VLD G1080C, and G1049C) were generated by site-directed mutagenesis (QuickChange Kit; Agilent, Santa Clara, CA, USA).
Munc13-1 C 1 -C 2 B-MUN fragment (residues 529-1407, EF, 1453-1531) was expressed in sf9 insect cell and purified as previously described [16] . Other proteins were expressed in Escherichia coli BL21 DE3 cells and purified as previously described [13, 30, 31] .
Fluorescence anisotropy
Fluorescence anisotropy assays were performed on PTI QM40 fluorescence spectrophotometer equipped with polarizers. Single cysteine variants were labeled with BODIPY FL N-(2-aminoethyl)-maleimide (BDPY) according to manufacturer's instruction (Molecular Probes, Eugene, OR, USA). All the experiment were carried out at 28°C in a 1-cm quartz cuvette in 25 mM HEPES-K + pH 7.60, 150 mM KCl, 10% glycerol (v/v), 0.2 mM tris-(2-carboxyethyl)-phosphine (TCEP; Sigma, St. Louis, MO, USA). The G factor was determined according to the equation as follow:
where I is the fluorescence intensity, the two-letter subscripts indicate the direction of excitation and emission light respectively (H, horizontal, 90°; V, vertical, 0°). The anisotropy (r) was calculated by the equation:
Fluorescence resonance energy transfer (FRET) assays
Fluorescence resonance energy transfer (FRET) assays were carried out in PTI QM40 fluorescence spectrophotometer at 37°C using a 1-cm quartz cuvette. For EDTA recovery experiment, general procedures were depicted as a schematic diagram. In brief, the cytoplasmic domain of syntaxin-1a (residues 2-253) was preincubated with tetramethylrhodamine-5-maleimide (TMR)-labeled SNAP-25 (S187C) and VLD at 4°C overnight. 0.5 lM assembled tomosyn-SNARE complex (with or without Munc18) was initially disassembled by NSF/a-SNAP in the presence of 2 mM ATP-2Na + and 2 mM MgCl 2 . After 40 min incubation at 37°C, 2 lM BDPY-labeled cytoplasmic domain of synaptobrevin-2 (residues 29-93, S61C) was incorporated into the reaction followed by addition of 5 mM EDTA. Donor fluorescence was monitored with excitation and emission wavelength of 485 nm and 513 nm, respectively. For other SNARE pairing experiments using FRET method, schematic diagrams were shown in the figures. Donor fluorescence was monitored with excitation and emission wavelength of 485 and 513 nm respectively.
Liposome preparation
All of the lipids were purchased from Avanti Polar Lipids (USA). The lipid mixtures were dried in glass tubes with nitrogen flow followed by vacuuming for 4 h. For liposome coflotation assay, the liposome compositions are 59% POPC, 20% POPE, 20% DOPS, and 1% brain PI(4,5)P 2 . For lipid mixing assays, 34% POPC, 20% POPE, 20% DOPS, 20% Cholesterol, 1% PI(4,5)P 2 , and 5% DAG for t-liposome and 45% POPC, 17% POPE, 15% DOPS, 20% Cholesterol, 1.5% NBD-PE, 1.5% Rhodamine-PE for v-liposome. Dried lipid films were resuspended in a buffer containing 25 mM HEPES-K + pH 7.60, 150 mM KCl, 10% glycerol (v/v), 1% CHAPS (Amresco, Solon, OH, USA) and 0.2 mM TCEP and vortexed for 5 min. Purified proteins were added to the mixture to reach a protein-to-lipid ratio of 1 : 500 (for syntaxin-1a/ SNAP-25 and synaptobrevin-2) and 1 : 800 (for synaptotagmin-1). The liposome protein mixtures were incubated at room temperature for 30 min and then dialyzed extensively with 1 gÁL À1 Bio-beads SM2 (BioRad, Hercules, CA, USA) three times in 25 mM HEPES-K + , pH 7.60, 150 mM KCl, 10% glycerol (v/v), 0.2 mM TCEP at 4°C. For content mixing assay, the t-liposome was the same with lipid mixing assays, while the v-liposome contains 45% POPC, 20% POPE, 15% DOPS, and 20% Cholesterol. Lipid films were resuspended and dissolved in as described above but supplied with 40 mM sulforhodamine B (Sigma). Excess unencapsulated sulforhodamine B was removed by extensive dialysis.
Liposome coflotation
Full-length syntaxin-1a containing liposome (1 mM total lipid, 59% POPC, 20% POPE, 20% DOPS, and 1% PI(4,5)P 2 ) was initially incubated with 4 lM SNAP-25 at 4°C overnight. The mixture was then incubated with 2 lM Munc18 at room temperature for 2 h. The proteoliposomes were prepared in a 40%:30%:0% discontinuous Histodenz (Sigma) density gradient using a SW55Ti rotor (Beckman Coulter, Brea, CA, USA) at 240 000 g for 1 h. Samples from the top and the bottom of the gradient (30 lL) were taken and analyzed by SDS/PAGE followed by Coomassie Brilliant Blue staining. Top samples were then diluted for other experiments.
Lipid mixing and content mixing assay
For lipid mixing assay, the components of t-liposome (syntaxin-1/SNAP-25/VLD) and v-liposome (synaptobrevin-2/synaptotagmin-1) were described above and indicated in the figures. Briefly, 60 lM t-liposomes (total lipids) were mixed with 50 lM v-liposomes (total lipids), 1 lM NSF, 0.5 lM a-SNAP, 2 mM MgCl 2 , and 2 mM ATP, 0.5 lM C 1 -C 2 B-MUN fragment, 1 lM Munc18, additional 5 lM SNAP-25 and 1 mM Ca 2+ . The experiment was carried out at 37°C using a 1-cm quartz cuvette on PTI QM-40 fluorescence spectrophotometer with an excitation wavelength of 460 nm and an emission wavelength of 538 nm. For content mixing assays, general procedures were similar to lipid mixing assays, except with an excitation wavelength of 565 nm and an emission wavelength of 580 nm.
Sequence alignment
Sequence alignment was performed with Clustal Omega and interpreted with ESPRIPT 3.0 [32] .
Graphing and mathematical methods Prism 6.01 (GraphPad Software, La Jolla, CA, USA) was used to graph and perform nonlinear curve fitting.
Results
Formation of the tomosyn-SNARE complex with and without Munc18
Either the tomosyn-VLD or synaptobrevin-2 is able to form a stable ternary complex with syntaxin-1 and SNAP-25. However, the formed tomosyn-SNARE complex is less stable than the actual SNARE complex containing synaptobrevin-2, as the tomosyn-SNARE complex is not SDS-resistant [25] . In line with this, fluorescent anisotropy experiments showed that the assembly kinetics of the tomosyn-SNARE complex was remarkably slower than that of the SNARE complex containing synaptobrevin-2 (Fig. 1A,B) . In addition, sequence alignment revealed low homology between the tomosyn-VLD and synaptobrevin-2 majorly on their N-terminal region (Fig. 1C) , suggesting that the comparably slow assembly rate and relative instability of the tomosyn-SNARE complex might due to the poor fidelity with SNAP-25 and syntaxin-1 on the N-terminal SNARE pairing.
In fact, tomosyn interacts and colocalizes with syntaxin-1 and SNAP-25 on the plasma membrane before synaptobrevin-2 arrival [33] . It would be expected that formation of the tomosyn-SNARE complex is ahead of the actual trans-SNARE complex formation. Indeed, our fluorescent anisotropy experiments showed that preincubation of the tomosyn-VLD with syntaxin-1 and SNAP-25 completely blocked synaptobrevin-2 entry (Fig. 1D ). This data is consistent with previous results [25] , suggesting that tomosyn is capable of trapping syntaxin-1 and SNAP-25 into the tomosyn-SNARE complex that precludes synaptobrevin-2 binding.
In addition to tomosyn, Munc18-1 was found to colocalize with syntaxin-1 and SNAP-25 on the plasma membrane. Recent in vitro experiments suggested that Munc18-1 stabilizes a 1 : 1 syntaxin-1/SNAP-25 complex to promote fast synaptobrevin-2 binding [21] . Indeed, our liposome coflotation experiments showed that Munc18-1 bound to membrane-embedded syntaxin-1/SNAP-25 complexes (Fig. 1E) , illustrating the formation of a ternary syntaxin-1/SNAP-25/Munc18-1 complex. Next, we carried out FRET experiments to test whether the tomosyn-VLD likewise inhibits binding of synaptobrevin-2 to liposomes containing the syntaxin-1/SNAP-25 complex in the absence and presence of Munc18-1. As anticipated, synaptobrevin-2 efficiently bound to liposomes bearing the syntaxin-1/ SNAP-25 complex in the absence and presence of Munc18 (Fig. 1F) . Strikingly, in either case, further addition of the tomosyn-VLD resulted in complete loss of synaptobrevin-2 entry (Fig. 1F) , suggesting a competition between the tomosyn-VLD and Munc18-1 for binding with the syntaxin-1/SNAP-25 complex and that the tomosyn-SNARE complex dominates over the syntaxin-1/SNAP-25/Munc18-1 complex. Nevertheless, we expected that the syntaxin-1/SNAP-25/Munc18-1 complex seems unlikely to represent the starting point of SNARE complex formation in the presence of tomosyn. BDPY and TMR, which act as fluorescent donor and acceptor, were separately labeled to synaptobrevin-2 and SNAP-25 respectively. Disassembly of tomosyn-SNARE complex is not shown in (E). Traces in (E) begin with the addition of EDTA and BDPY-labeled synaptobrevin-2 into the disassembled tomosyn-SNARE complex. neg.ctrl. represents excess unlabeled soluble synaptobrevin-2 was applied. Syx, syntaxin-1; SN25, SNAP-25; Syb, synaptobrevin-2; M18, Munc18-1.
Transit of syntaxin-1 from the tomosyn-SNARE complex to the Munc18-1/syntaxin-1 complex
We then sought to explore how syntaxin-1 and/or SNAP-25 could be escaped from the 'nonfusogenic' tomosyn-SNARE complex. Given the activity of NSF and a-SNAP in disassembling the SNARE complex [34] , we turned to investigate whether NSF and a-SNAP could disassemble the tomosyn-SNARE complex to release syntaxin-1. Our fluorescence anisotropy experiments in solution showed that the tomosyn-SNARE complex was effectively disassembled by NSF/a-SNAP in the presence of ATP and Mg 2+ , similar to that observed for the SNARE complex containing synaptobrevin-2 ( Fig. 2A,B) . Strikingly, when tomosyn-SNARE complexes were reconstituted on the liposomes, NSF and a-SNAP exhibited a much higher disassembly activity (Fig. 2C) , due likely because of an enhanced a-SNAP activity caused by membrane binding as previously suggested [35] .
Since the tomosyn-SNARE complex can be effectively disassembled by NSF/a-SNAP, we next investigated whether the released syntaxin-1 could be captured by Munc18-1, because of the high binding affinity between Munc18-1 and the isolated syntaxin-1. If it were the case, after terminating NSF/a-SNAP activity by EDTA (chelating Mg 2+ ), addition of Munc18-1 leading to the formation of the Munc18-1/ syntaxin-1 complex would preclude the recovery of SNARE complex assembly (in the absence of Munc13-1; Fig. 2D , left panel), as transition of the Munc18-1/syntaxin-1 complex to the SNARE complex strictly requires Munc13-1 catalysis [12, 13] ; otherwise, syntaxin-1 and SNAP-25 disassembled from the tomosyn-SNARE complex would be able to assembled into the SNARE complex when synaptobrevin-2 is additionally introduced (Fig. 2D, right  panel) .
The preassembled tomosyn-SNARE complex containing TMR-labeled SNAP-25 was first extensively disassembled by NSF/a-SNAP with and without Munc18-1. Addition of EDTA and BODIPY FLlabeled synaptobrevin-2 caused robust FRET signal (characterized by the decrease in donor fluorescence) in the reaction without Munc18-1 (Fig. 2D,E) , indicating the reassembly of free syntaxin-1 with SNAP-25 and synaptobrevin-2 in the absence of Munc18-1. However, no FRET was detected in the reaction when Munc18-1 was added (Fig. 2D,E) . These data suggest that once syntaxin-1 is disassociated from the tomosyn-SNARE complex by NSF/a-SNAP, it would be captured by Munc18-1 to form the Munc18-1/syntaxin-1 complex.
Transit of syntaxin-1 from the Munc18-1/ syntaxin-1 complex to the SNARE complex requires synaptobrevin-2 but not the tomosyn-VLD In a physiological context, SNARE complex formation is highly regulated by the active-zone protein Munc13-1 [9] . Previous studies have shown that the Munc13-1 MUN domain specifically catalyzes the transit of syntaxin-1 from the Munc18-1/syntaxin-1 complex to the SNARE complex with the addition of SNAP-25 and synaptobrevin-2. We next investigated whether the MUN domain is able to catalyze tomosyn-SNARE complex formation starting with the Munc18-1/syntaxin-1 complex in the presence of SNAP-25 and the tomosyn-VLD. By using the fluorescent anisotropy assay (Fig. 3A) , we confirmed that the MUN domain strongly stimulated the Munc18-1/syntaxin-1 complex to the SNARE complex transition in the presence of SNAP-25 and synaptobrevin-2 (Fig. 3B) . However, we found that the MUN domain failed to catalyze tomosyn-SNARE complex formation when starting with the Munc18-1/syntaxin-1 complex, SNAP-25 and the tomosyn-VLD (Fig. 3B) . As expected, when both synaptobrevin-2 and excess of the tomosyn-VLD were applied together with the Munc18-1/syntaxin-1 complex, SNAP-25, and the MUN domain, we detected efficient formation of the actual SNARE complex containing synaptobrevin-2 (Fig. 3B) . These results clearly show that when starting with the Munc18-1/syntaxin-1 complex (with Munc13-1 catalysis), the tomosyn-VLD could not interfere with synaptobrevin-2 for actual SNARE complex formation any more.
All the data presented above suggest that NSF/a-SNAP assists with Munc18-1 to promote the transit of syntaxin-1 from the tomosyn-SNARE complex to the Munc18-1/syntaxin-1 complex; afterward, Munc13-1 catalyzes the transit of syntaxin-1 from the Munc18-1/ syntaxin-1 complex to the SNARE complex with the addition of SNAP-25 and synaptobrevin-2 in the presence of the tomosyn-VLD. Therefore, we aimed to monitor this process in a membrane-containing environment (Fig. 3C) . We reconstituted full-length synaptobrevin-2 in v-liposomes as well as the tomosyn-SNARE complex containing a C-terminal truncated SNAP-25 (SNAP-25 D9, which could be assembled into the trans-SNARE complex without inducing membrane fusion [36] ) in t-liposomes, followed by monitoring trans-SNARE complex formation using FRET experiments as previously described [31] . As expected, no FRET was observed when v-liposomes were mixed with t-liposomes (containing the tomosyn-SNARE complex) no matter if NSF/a-SNAP was added (Fig. 3D) , confirming an inhibitory role of the tomosyn-VLD in trans-SNARE complex formation deficient in Munc18-1 and Munc13-1. However, a robust FRET signal was detected with further inclusion of Munc18-1 and Munc13-1 (C 1 -C 2 B-MUN) in the presence of NSF/a-SNAP (Fig. 3D) , suggesting that Munc18-1 and Munc13-1 effectively promote the formation of the trans-SNARE complex between two membranes in a manner resistant to the inhibitory function of the tomosyn-VLD.
Membrane fusion reconstituted with tomosyn, NSF/a-SNAP, Munc18, and Munc13
Previous studies have successfully reconstituted the vital functions of NSF/a-SNAP, Munc18-1, and Munc13-1 in SNARE-mediated membrane fusion in vitro [16, 37] . We next sought to reconstitute the function of tomosyn in membrane fusion. In our reconstitution system (Fig. 4A,C) , the fusion reactions between t-liposomes reconstituted with the syntaxin-1/SNAP-25 complex and v-liposomes bearing synaptobrevin-2 and full-length synaptotagmin-1 were characterized by lipid-mixing and content-mixing experiments as described before [16] . We observed that preincubation of the tomosyn-VLD with t-liposomes strongly inhibited the fusion with v-liposomes (Fig. 4B,D) . Similarly, no membrane fusion was observed with further addition of NSF/a-SNAP in the presence of the tomosyn-VLD (Fig. 4B,D) , due to the disassembly of the SNARE complex by NSF/ a-SNAP. These data support an inhibitory function of tomosyn in membrane fusion in the absence of Munc18-1 and Munc13-1. Intriguingly, when Munc18-1 and Munc13-1 (C 1 -C 2 B-MUN) were added together with NSF/a-SNAP (with ATP and Mg 2+ ) to t-liposomes containing the preassembled tomosyn-SNARE complex, efficient membrane fusion of t-liposomes with v-liposomes was observed (Fig. 4B,  D) . These results are consistent with the data observed in Fig. 3D . As a control, efficient membrane fusion was observed when omitting the tomosyn-VLD throughout our reconstitution system (Fig. 4B,D) . Altogether, our results support the notion that Munc18-1 and Munc13-1 promote membrane fusion in a manner resistant to the inhibitory function of the tomosyn-VLD.
Discussion
Synaptic exocytosis depends on the efficient formation of SNARE complexes and is regulated by tomosyn. In this study, we have reconstituted SNARE complex formation and SNARE-mediated vesicle fusion reactions using purified presynaptic components to recapitulate tomosyn-regulated exocytosis pathways. Our data suggest that the tomosyn-VLD, in coordination with Munc18-1 and Munc13-1, likely serves to enhance the specificity for SNARE recognition and fusion, thus adding a further layer of regulation to the process of synaptic exocytosis.
Our data found that the syntaxin-1/SNAP-25 complex bound or not bound to Munc18-1 can be effectively trapped into the tomosyn-SNARE complex that precludes synaptobrevin-2 entry (Fig. 1) , suggesting that tomosyn likely functions to inhibit trans-SNARE complex formation between SV and the plasma membrane in the early stage of exocytosis. This finding is consistent with a previous study showing that the inhibitory function of the full-length of tomosyn dominates over the stimulatory activity of Munc18-1 in liposome fusion [38] . The inhibitory function of tomosyn appears to be essential for suppressing the reactivity of the syntaxin-1/SNAP-25 complex upstream of Munc18-Munc13 regulation, leaving the docked SV accumulated at the fusion sites without random fusion with the plasma membrane. However, it is structurally difficult to envision how syntaxin-1 can be escaped from the tomosyn-SNARE complex and participates in the formation of the actual SNARE complex containing synaptobrevin-2. In light of previous and current results (Fig. 2) , we conclude that NSF/a-SNAP can disassemble the tomosyn-SNARE complex effectively, in particular on membranes. Interestingly, the free syntaxin-1 disassociated from the tomosyn-SNARE complex by NSF/a-SNAP can be captured by Munc18-1, resulting in the formation of the 'closed' Munc18-1/syntaxin-1 complex (Fig. 2) , thus preventing SNARE complex assembly without the help of Munc13-1. Further, we demonstrated that the transition from the Munc18-1/syntaxin-1 complex to the SNARE complex catalyzed by Munc13-1 requires synaptobrevin-2 instead of the tomosyn-VLD (Fig. 3) . These evidence suggest that the reactive syntaxin-1/SNAP-25 complex bound or not bound to Munc18-1 seems unlikely to represent a stable starting point for SNARE complex formation in exocytosis. Instead, the Munc18-1/syntaxin-1 complex is plausible to act as a well-defined starting point, as this complex is not only resistant to the tomosyn-VLD but also amenable to tight regulation by Munc13-1.
As observed, Munc13-1 catalyzes the transition from the Munc18-1/syntaxin-1 complex to the SNARE complex, rather than to the tomosyn-SNARE complex (Fig. 3) . These data strongly suggest that synaptobrevin-2 is specific for Munc18-Munc13-dependent SNARE complex formation. In addition, these data are consistent with previous biochemical and structural studies indicating a direct interaction between the Munc18-1 domain 3a and synaptobrevin-2 [39] [40] [41] . Although the primary sequence of the tomosyn-VLD shares high identity with that of synaptobrevin-2, the conserved residues are mainly distributed on the Cterminal hydrophobic layers between the two RSNAREs (Fig. 1C) . Thus, the variability among the N-terminal hydrophobic layers on the two R-SNARE motifs may explain why Munc18-1 recognizes synaptobrevin-2 but not the tomosyn-VLD. Moreover, the fidelity of synaptobrevin-2 entry might be contributed partly by its recognition on Munc13-1, as it was recently observed that Munc13-1 promotes the proper SNARE complex assembly via a direct interaction with synaptobrevin-2 [14] .
Meanwhile, although the energized syntaxin-1/ SNAP-25/Munc18-1 tripartite complex is unlikely to represent the starting point for fusion as discussed above, it remains unclear whether this complex could be transiently formed subsequent to the activation of the Munc18-1/syntaxin-1 complex by Munc13-1. Indeed, recent results obtained with single-molecule experiments suggested that when starting with the Munc18-1/syntaxin-1 complex, Munc13-1 binding leads to a partially open state of syntaxin-1 that is accessible for SNAP-25 entry [42] , and Munc13-1 and Munc18-1 acts together to ensure assembly of the proper syntaxin-1/SNAP-25 arrangement in the presence of synaptobrevin-2 [14] . These data raise a possibility that the syntaxin-1/SNAP-25/Munc18-1 complex might present as an intermediate during the transition between the Munc18-1/syntaxin-1 complex and SNARE complex. Hence, the alternative binding modes of Munc18-1 with syntaxin-1 indicate the flexibility and dynamic with which Munc18-1 can associate with various states of syntaxin-1 and play correspondingly inhibitory and stimulatory roles at different stages of SNARE complex formation.
In agreement with these evidence, our in vitro reconstitution experiments successfully recapitulated the vital function of tomosyn in SNARE-mediated membrane fusion, shedding light on the mechanism for the tomosyn-VLD in exocytosis which depends on its interplay with other key components (Fig. 4E): (a) the tomosyn-VLD traps syntaxin-1 and SNAP-25 into a nonfusogenic SNARE complex formation, which would suppress the reactivity of the syntaxin-1/SNAP-25 complex thus rendering the docked SV accumulated at the fusion sites without random fusion with the plasma membrane; (b) starting with the tomosyn-SNARE complex, Munc18-1, assisted with NSF and a-SNAP, promotes release of the syntaxin-1 from tomosyn trapping and facilitates assembly of the Munc18-1/syntaxin-1 complex, establishing a proper template for Munc13-1 and synaptobrevin-2 binding; and (c) Munc13-1 specifically catalyzes the transition of the Munc18-1/syntaxin-1 complex to the final SNARE complex in a manner resistant to the inhibitory function of tomosyn. Taken together, we conclude that the regulatory function of tomosyn in exocytosis may be in part accomplished by its actions on ensuring the proper activation sequence of SNARE assembly in coordination with Munc18-1 and Munc13-1.
